COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,537 Articles (22,881 medRxiv, 8,656 bioRxiv)

Most recent first Previous |  Page 1952: Articles 19511-19520  | Next

Structure-function investigation of a new VUI-202012/01 SARS-CoV-2 variant
Singh, J., Ehtesham, N. Z., Rahman, S. A., Hasnain, S. E.
10.1101/2021.01.01.425028 — Posted: 2021-01-04
Laboratory Biomarkers of COVID-19 Disease Severity and Outcome: Findings from a Developing Country
Leulseged, T. W., Hassen, I. S., Ayele, B. T., Tsegay, Y. G., Abebe, D. S., Edo, M. G., Maru, E. H., Zewde, W. C., Naylor, L. K., Semane, D. F., Deresse, M. T., Tezera, B. B.
10.1101/2020.12.29.20248976 — Posted: 2021-01-04
Accuracy of the Veterans Health Administration COVID-19 (VACO) Index for predicting short-term mortality among 1,307 Yale New Haven Hospital inpatients and 427,224 Medicare patients
King, J. T., Yoon, J. S., Bredl, Z. M., Habboushe, J. P., Walker, G. A., Rentsch, C. T., Tate, J. P., Kashyap, N. M., Hintz, R. C., Chopra, A. P., Justice, A. C.
10.1101/2021.01.01.20249069 — Posted: 2021-01-04
On the lag between deaths and infections in the first phase of the Covid-19 pandemic
Chrusciel, P., Szybka, S.
10.1101/2021.01.01.21249115 — Posted: 2021-01-04
Mental health of health care workers during the COVID-19 pandemic and evidence-based frameworks for mitigation: A rapid review
Major, A., Hlubocky, F. J.
10.1101/2021.01.03.21249166 — Posted: 2021-01-04
What is the value of community oximetry monitoring in people with SARS-CoV-2? A prospective, open-label clinical study
Wilcock, J., Grafton-Clarke, C., Coulson, T.
10.1101/2021.01.03.21249168 — Posted: 2021-01-04
How vaccination and contact isolation might interact to suppress transmission of Covid-19: a DCM study
Friston, K. J., Costello, A., Flandin, G., Razi, A.
10.1101/2021.01.03.20248972 — Posted: 2021-01-04
The Impact of the November 2020 English National Lockdown on COVID-19 case counts
Hunter, P. R., Brainard, J. S., Grant, A. R.
10.1101/2021.01.03.21249169 — Posted: 2021-01-04
SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection
Havervall, S., Jernbom Falk, A., Klingstrom, J., Ng, H., Greilert Norin, N., Gabrielsson, L., Salomonsson, A.-C., Isaksson, E., Rudberg, A.-S., Hellstrom, C., Andersson, E., Olofsson, J., Skoglund, L., Yousef, J., Pin, E., Christ, W., Olausson, M., Hedhammar, M., Tegel, H., Mangsbo, S., Phillipson, M., Manberg, A., Hober, S., Nilsson, P., Thalin, C.
10.1101/2021.01.03.21249162 — Posted: 2021-01-04
Autoimmune anti-DNA antibodies predict disease severity in COVID-19 patients
Gomes, C., Zuniga, M., Crotty, K. A., Qian, K., Hsu Lin, L., Argyropoulos, K., Li, H., Cotzia, P., Rodriguez, A.
10.1101/2021.01.04.20249054 — Posted: 2021-01-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).